Target prediction indicated a top-ranked list of possible AD-related targets of these compounds, which demonstrated their potentials for combating the complexing of the disease in multiple facets (i.e., neuroinflammation, neuronal cell death, and misfolded proteins) under the SIRT1 regulation. This evidence concerns the gene SIRT1 and Alzheimer disease.